Background Vitiligo is a chronic skin disorder characterised by patchy loss of skin colour.
Some people experience itching before the appearance of a new patch. It affects people of …

Despite historical mischaracterization as a cosmetic condition, patients with the autoimmune
disorder vitiligo experience substantial quality‐of‐life (QoL) burden. This systematic …

Vitiligo is an acquired, chronic condition characterised by depigmentation of the epidermis
or by destruction/loss of melanin. Skin cells (melanocytes) are responsible for producing …

Vitamin D is one significant prohormone substance in human organ systems. It is a steroidal
hormone produced in the skin upon exposure to UVB rays. This paper presents a systematic …

Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and
can cause significant psychological stress and stigmatization. Recent advances have shed …

Vitiligo affects around 1% of the world's population. Despite it being relatively common, there
is still no effective treatment. The objective of this study was to update the Cochrane …

Vitiligo is an asymptomatic but cosmetically disfiguring disorder that results in the formation
of depigmented patches on skin and/or mucosae. Vitiligo can be segmental or non …

Vitiligo is one of the most common cutaneous disorders of depigmentation. Although its
underlying causes are still being studied and no definitive cure currently exists, recent …

Topical corticosteroids (TCs) are the pillars of dermatotherapeutics. These drugs are the
“magic molecules,” provided they are used judiciously and appropriately, following a rational …

Survival analysis is concerned with “time to event” data. Conventionally, it dealt with cancer
death as the event in question, but it can handle any event occurring over a time frame, and …